The company usually posts poor financials for mid or long term investments.
The company has solid fundamentals for a short-term investment strategy.
Strengths
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
The stock is in a well-established, long-term rising trend above the technical support level at 6.3 NZD
Weaknesses
As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The group shows a rather high level of debt in proportion to its EBITDA.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
With an enterprise value anticipated at 6.43 times the sales for the current fiscal year, the company turns out to be overvalued.
With an expected P/E ratio at 80.35 and 79.2 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
